E
Sharp Therapeutics Corp. SHRX.V
TSX
Recommendation
Prev Close
$0.80
Volume
--
Avg Vol (90D)
574
Market Cap
$16.19M
Dividend & Yield
--
52-Week Range
$0.80 - $2.28
P/E (TTM)
--
EPS (TTM)
-$37.36
My Lists My Alerts
Access our Premium Ratings
Get Access
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Index
Headlines
There are no news to display.
Income Statement
Total Revenue (TTM)
--
EBITDA (TTM)
-$3.12M
EBIT (TTM)
-$3.15M
Net Income (TTM)
-$5.20M
Balance Sheet
Total Assets (Q)
$1.39M
Total Debt (Q)
$15.03M
Total Liabilities (Q)
$15.90M
Book Value Per Share (Q)
-$10.42
Cash Flow
Cash from Operations (TTM)
-$2.18M
Cash from Investing (TTM)
-$14.40K
Cash from Financing (TTM)
$2.12M
Net Change in Cash (TTM)
-$74.00K
Filings
Filing Date
Friday, November 1, 2024
Period Date
Sunday, June 30, 2024
Next Filing
Week of Oct 27 and 31 (est)
Price History
Loading...
Beta
--
7-Day Total Return
18.13%
30-Day Total Return
-2.27%
60-Day Total Return
-2.27%
90-Day Total Return
104.76%
Year to Date Total Return
104.76%
1-Year Total Return
104.76%
2-Year Total Return
--
3-Year Total Return
--
5-Year Total Return
--
52-week Low
Apr 16, 2025 - $0.80
52-week High
Apr 01, 2025 - $2.28
Valuation
Market Cap
$16.19M - Nano Cap
Enterprise Value
$30.71M
Price/Sales (TTM)
--
Price/Book (Q)
-0.08
Dividends and Shares
Shares Outstanding
139.30K
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
www.sharptx.com
Phone Number
412-206-5303
Address
2403 Sidney Street
Pittsburgh, PA 15203
Country
United States
Year Founded
--
Business Description
Sector
Health Care
Industry
Pharmaceuticals, Biotechnology and Life Sciences
Sharp Therapeutics Corp., a biology technology company, develops medicines specific for genetic diseases. It engages in the development of the CoreX biology, AlloChem chemistry, and Disco/Mine... more